Longitudinal dynamics of antibody responses in recovered COVID-19 patients

作者：Meng‐Li Cheng, Huiying Liu, Hui Zhao, Guoqing Wang, Chao Zhou, Jing Zheng, Xiaofeng Li, Fan Li, Changqing Bai, Cheng‐Feng Qin · 发表于：Signal Transduction and Targeted Therapy · 年份：2021 · DOI：10.1038/s41392-021-00559-7 · 被引用次数：18 · 研究领域：SARS-CoV-2 and COVID-19 Research、COVID-19 Clinical Research Studies、Long-Term Effects of COVID-19

The coronavirus disease 2019 (COVID-19) has resulted in more than 66.5 million cases globally in more than 191 countries with over 1,529,000 mortalities as of 6 December. Currently, the COVID-19 continued to spread around the world, while the duration of antibody lasts and antibody level remained poorly understood, which are primary for safe and effective antiviral treatments and vaccines in the future. In this study, we comprehensively characterized the longitudinal changes of antibodies in recovered patients from 5–7 to 34–42 weeks after symptom onset.